Duspatalin side effects - from FDA reports


Summary

In this review, we analyze Duspatalin side effects by the time on the drug, gender and age of the people who have side effects while taking Duspatalin. The review is based on 199 people who have side effects while taking the drug from FDA, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


Duspatalin

Duspatalin has active ingredients of mebeverine hydrochloride. It is often used in irritable bowel syndrome. (latest outcomes from Duspatalin 212 users)

On Jul, 21, 2017

199 people who take Duspatalin are studied.


Number of reports submitted per year:

Duspatalin side effects.

Most common side effects over time *:

< 1 month:
  • neurotoxicity
  • hepatic encephalopathy
  • encephalopathy
  • hodgkin's disease
  • hyponatraemia
  • blood creatine increased
  • colitis ulcerative
  • disease progression
  • maternal exposure during pregnancy
1 - 6 months:
  • confusional state
2 - 5 years:
  • systemic inflammatory response syndrome
not specified:
  • weight decreased
  • jaundice
  • abdominal pain
  • international normalised ratio increased
  • asthenia
  • dyspnoea
  • vomiting
  • colitis ulcerative
  • gastrointestinal hypomotility
  • hyperkalaemia

Most common side effects by gender *:

female:
  • dyspnoea
  • international normalised ratio increased
  • weight decreased
  • confusional state
  • gastrointestinal hypomotility
  • hyperkalaemia
  • abdominal pain
  • crohn's disease
  • drug-induced liver injury
  • lower gastrointestinal haemorrhage
male:
  • jaundice
  • asthenia
  • colitis ulcerative
  • abdominal pain
  • weight decreased
  • encephalopathy
  • gastrointestinal inflammation
  • hodgkin's disease
  • hyponatraemia
  • muscle disorder

Most common side effects by age *:

10-19:
  • pathogen resistance
  • weight increased
20-29:
  • hodgkin's disease
  • colitis ulcerative
30-39:
  • crohn's disease
  • depressed level of consciousness
  • duodenitis
  • erythema nodosum
  • skin discolouration
  • steatorrhoea
40-49:
  • abdominal pain
  • asthenia
  • gastrointestinal inflammation
  • suicidal ideation
  • surgery
  • acute febrile neutrophilic dermatosis
  • acute generalised exanthematous pustulosis
  • agranulocytosis
  • chest pain
  • injection site haematoma
50-59:
  • colitis ulcerative
  • asthenia
  • encephalopathy
  • thoracic vertebral fracture
  • arthralgia
  • cholecystitis
  • diarrhoea
  • dyspnoea
  • hyperventilation
  • hypoglycaemia
60+:
  • jaundice
  • weight decreased
  • international normalised ratio increased
  • confusional state
  • dyspnoea
  • gastrointestinal hypomotility
  • hepatic encephalopathy
  • hyperkalaemia
  • hyponatraemia
  • abdominal pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Are you taking Duspatalin?

Related studies

All Duspatalin side effects from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Duspatalin (mebeverine hydrochloride) is often used to treat irritable bowel syndrome. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it: